Diagnostics and bioinformatics

Detailed segment division:

• Diagnostic antibodies
• Peptides, conjugates, oligonucleotides synthesis
• DNA diagnostics
• Biosensors, biomonitoring
• Genome analysing techniques
• Bio-data-informatics (set of tools, which is applied to solve data handling and processing problems in biological research, eg. Genome sequencing)
• Bio-informatics (application of biological principles to information processing for technical applications)

Bio-informatics (application of biological principles to information processing for technical applications)

Genomics, particularly sequencing and characterization of expressed human genes, has created new opportunities for drug discovery. Knowledge of all the human genes and their functions may allow effective preventive measures, and change drug research strategy and drug discovery development processes. Pharmacogenomics is the application of genomic technologies such as gene sequencing, statistical genetics, and gene expression analysis to drugs in clinical development. It applies the large-scale systematic approaches of genomics to speed the discovery of drug response markers, whether they act at the level of the drug target, drug metabolism, or disease pathways. The potential implication of genomics and pharmacogenomics in clinical research and clinical medicine is that disease could be treated according to genetic and specific individual markers, selecting medications and dosages that are optimized for individual patients.

Records in database for Bio-informatics (application of biological principles to information processing for technical applications) segmant:

Companies (), Research Institutes (), Government and NGO (), Service suppliers (), Material suppliers (), Projects (), Links (), Books (), Journals (), Legislative environment (), Czech Events (), International Events ()